Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis
Article first published online: 13 SEP 2011
© 2011 Blackwell Publishing Ltd
Tropical Medicine & International Health
Volume 16, Issue 12, pages 1541–1551, December 2011
How to Cite
Setia, M. S., Shinde, S. S., Jerajani, H. R. and Boivin, J.-F. (2011), Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis. Tropical Medicine & International Health, 16: 1541–1551. doi: 10.1111/j.1365-3156.2011.02873.x
- Issue published online: 15 NOV 2011
- Article first published online: 13 SEP 2011
Table S1. Publication details, Inclusion/exclusion criteria, description of study population, findings, side effects/reactions/relapses and other characteristics of the studies that compared ROM therapy with standard WHO therapy.
Table S2. Description (place of study, study population and treatment, outcomes and relapses) of the observational studies using ROM therapy in the treatment of leprosy.
|TMI_2873_sm_TableS1-S2.doc||103K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.